These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 30121613)

  • 1. Small volume plasma exchange for Guillain-Barré syndrome in resource-limited settings: a phase II safety and feasibility study.
    Islam B; Islam Z; Rahman S; Endtz HP; Vos MC; van der Jagt M; van Doorn PA; Jacobs BC; Mohammad QD
    BMJ Open; 2018 Aug; 8(8):e022862. PubMed ID: 30121613
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term outcomes of plasma exchange versus intravenous immunoglobulin for the treatment of Guillain-Barré Syndrome: A double-blind, randomized clinical trial.
    Haridy NA; Shehab MM; Khedr EM
    Restor Neurol Neurosci; 2023; 41(5-6):203-217. PubMed ID: 38217554
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictors of long-term health-related quality of life in Guillain-Barré syndrome: A hospital-based study.
    Khedr EM; Mahmoud DM; Ahmed GK; Haridy NA
    Clin Neurol Neurosurg; 2023 Dec; 235():108026. PubMed ID: 37913589
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuroprognostication: Guillain-Barré Syndrome.
    Traub R; Chaudhry V
    Semin Neurol; 2023 Oct; 43(5):791-798. PubMed ID: 37788681
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of Guillain-Barré syndrome in Bangladesh: Clinical practice, limitations and recommendations for low- and middle-income countries.
    Papri N; Islam Z; Ara G; Saha T; Leonhard SE; Endtz HP; Jacobs BC; Mohammad QD
    J Peripher Nerv Syst; 2023 Dec; 28(4):564-577. PubMed ID: 37698165
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma exchange in neurology patients-experience from single center in Montenegro.
    Roganovic M; Erakovic J; Radulovic L; Perunicic S; Milikic D; Vujovic B; Idrizovic Z; Vujovic S; Debeljevic M; Gluscevic S
    Ther Apher Dial; 2024 Feb; 28(1):125-130. PubMed ID: 37641163
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of eculizumab in Guillain-Barré syndrome: A phase 3, multicenter, double-blind, randomized, placebo-controlled clinical trial.
    Kuwabara S; Kusunoki S; Kuwahara M; Yamano Y; Nishida Y; Ishida H; Kasuya T; Kupperman E; Lin Q; Frick G; Misawa S
    J Peripher Nerv Syst; 2024 Sep; 29(3):339-349. PubMed ID: 38987228
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phase IIB Randomized Trial on the Use of 4-Aminopyridine in Guillain-Barré Syndrome.
    Meythaler JM; Brunner RC; Peduzzi J
    Arch Rehabil Res Clin Transl; 2021 Jun; 3(2):100123. PubMed ID: 34179759
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of Teleconsultation-Based Rehabilitation in Children with Landry-Guillain-Barré Syndrome: An Open Label Randomized Controlled Trial (Tele Rehab-LGBS Trial).
    Pravallika R; Suthar R; Patil A; Malviya M; Saxena S; Saini L; Bansal A
    Indian J Pediatr; 2024 May; 91(5):455-462. PubMed ID: 37889455
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and Safety of Therapeutic Plasma Exchange in Children with Neuroimmunological Disorders: A Limited Unicentral Study.
    Nikkhah A; Nasehi MM; Momtazmanesh N; Etemad K; Hajatnia S
    Iran J Child Neurol; 2024; 18(2):31-41. PubMed ID: 38617399
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluating Risk Factors for Developing Allergic Reactions during Plasma Exchange Using Fresh-frozen Plasma: A Single-center Retrospective Study.
    Abe T; Aoyama T; Takeuchi Y
    Intern Med; 2023 Oct; 62(19):2803-2811. PubMed ID: 36792201
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Successful Combination of Fresh Frozen Plasma and Albumin 5% in Plasma Exchange for a Patient with Concurrent Thyroid Storm and Guillain-Barré Syndrome: A Rare Case Report.
    Bui-Thi HD; Tran-Viet T; Trinh-Hoang KT
    Tohoku J Exp Med; 2024 Sep; 263(3):169-173. PubMed ID: 38897965
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma exchange as a cost-effective option for treating Guillain-Barré syndrome.
    Buenz EJ; Parry GJ; Ranta A
    Ther Adv Neurol Disord; 2017 Jan; 10(1):76-77. PubMed ID: 28450897
    [No Abstract]   [Full Text] [Related]  

  • 14. Nationwide study of therapeutic plasma exchange vs intravenous immunoglobulin in Guillain-Barré syndrome.
    Beydoun HA; Beydoun MA; Hossain S; Zonderman AB; Eid SM
    Muscle Nerve; 2020 May; 61(5):608-615. PubMed ID: 32052454
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Original research: Second IVIg course in Guillain-Barré syndrome with poor prognosis: the non-randomised ISID study.
    Verboon C; van den Berg B; Cornblath DR; Venema E; Gorson KC; Lunn MP; Lingsma H; Van den Bergh P; Harbo T; Bateman K; Pereon Y; Sindrup SH; Kusunoki S; Miller J; Islam Z; Hartung HP; Chavada G; Jacobs BC; Hughes RAC; van Doorn PA;
    J Neurol Neurosurg Psychiatry; 2020 Feb; 91(2):113-121. PubMed ID: 31586949
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacological treatment other than corticosteroids, intravenous immunoglobulin and plasma exchange for Guillain-Barré syndrome.
    Doets AY; Hughes RA; Brassington R; Hadden RD; Pritchard J
    Cochrane Database Syst Rev; 2020 Jan; 1(1):CD008630. PubMed ID: 31981368
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Axonal variants of Guillain-Barré syndrome: an update.
    Shang P; Zhu M; Wang Y; Zheng X; Wu X; Zhu J; Feng J; Zhang HL
    J Neurol; 2021 Jul; 268(7):2402-2419. PubMed ID: 32140865
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Update: the Miller Fisher variants of Guillain-Barré syndrome.
    Al Othman B; Raabe J; Kini A; Lee AG
    Curr Opin Ophthalmol; 2019 Nov; 30(6):462-466. PubMed ID: 31567467
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.